1. Home
  2. VYGR vs FLC Comparison

VYGR vs FLC Comparison

Compare VYGR & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.62

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Logo Flaherty & Crumrine Total Return Fund Inc

FLC

Flaherty & Crumrine Total Return Fund Inc

N/A

Current Price

$15.47

Market Cap

162.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
FLC
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.5M
162.4M
IPO Year
2015
2003

Fundamental Metrics

Financial Performance
Metric
VYGR
FLC
Price
$1.62
$15.47
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $14.22
N/A
AVG Volume (30 Days)
★ 945.7K
20.3K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $10,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$172.11
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$15.33
52 Week High
$5.19
$18.09

Technical Indicators

Market Signals
Indicator
VYGR
FLC
Relative Strength Index (RSI) 36.85 42.88
Support Level N/A $15.40
Resistance Level $2.04 $16.15
Average True Range (ATR) 0.15 0.19
MACD 0.01 -0.02
Stochastic Oscillator 16.22 9.46

Price Performance

Historical Comparison
VYGR
FLC

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: